The finding that prophylactic OM-MOG inhibited the migration of CD45-immunoreactive immune cells to the spinal cord was further supported by the results of adoptive transfer experiments using CD45.1 congenic mice. This evidence concerns the gene PTPRC and ocular melanoma.